Actemra (Tocilizumab) 80 mg/4 mL Concentrate for Solution for Infusion

Actemra is a biologic medication containing Tocilizumab, provided as a concentrated vial for intravenous infusion to manage inflammatory conditions.

EGP 2,763

In Stock

Delivery to governorates within 3-4 working days

Easy returns within 14 days

Specifications

SKU	CT-78
Color	Luscious Blackberry
Imported Or Local	Local

About the product›

About Actemra (Tocilizumab) 80 mg/4 mL

Actemra, as shown in "image_cd8ee5.png", is a specialized prescription-only medicine containing the active ingredient Tocilizumab. It is formulated as a 20 mg/mL concentrate, with each vial containing 80 mg in 4 mL of solution, designed specifically for intravenous infusion.

Therapeutic Use

Tocilizumab is a monoclonal antibody that inhibits the interleukin-6 (IL-6) receptor, effectively reducing inflammation associated with various autoimmune and inflammatory conditions.

Key Product Features

Concentration: 20 mg/mL (Total 80 mg per 4 mL vial).
Administration: Must be prepared as a solution for intravenous infusion.
Presentation: Single vial of 4 mL concentrate.
Manufacturer: Produced by Roche, ensuring pharmaceutical quality and reliability.

This product is a prescription-only medicine intended for use by healthcare professionals. Please keep out of reach of children and follow strict clinical guidelines for preparation and administration.